Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.

Euden J, Albur M, Bestwick R, Bond S, Brookes-Howell L, Dark P, Gerver S, Grozeva D, Hamilton R, Heginbothom M, Hellyer T, Henley J, Hope R, Hopkins S, Howard P, Howdon D, King N, Knox-Macaulay C, Llewelyn M, Maboshe W, McCullagh I, Ogden M, Pallmann P, Parsons H, Partridge D, Powell N, Prestwich G, Richman C, Shaw D, Shinkins B, Szakmany T, Thomas-Jones E, Todd S, Webb E, West R, Carrol E, Sandoe J, PEACH Study Group

Open source

DOI
10.3310/ggff9393
Published
2025 Nov
Container
Health technology assessment (Winchester, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3310/ggff9393,
  title = {Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.},
  author = {Euden J and Albur M and Bestwick R and Bond S and Brookes-Howell L and Dark P and Gerver S and Grozeva D and Hamilton R and Heginbothom M and Hellyer T and Henley J and Hope R and Hopkins S and Howard P and Howdon D and King N and Knox-Macaulay C and Llewelyn M and Maboshe W and McCullagh I and Ogden M and Pallmann P and Parsons H and Partridge D and Powell N and Prestwich G and Richman C and Shaw D and Shinkins B and Szakmany T and Thomas-Jones E and Todd S and Webb E and West R and Carrol E and Sandoe J and PEACH Study Group},
  year = {2025},
  journal = {Health technology assessment (Winchester, England)},
  doi = {10.3310/ggff9393},
  url = {https://doi.org/10.3310/ggff9393}
}

RIS

TY  - JOUR
TI  - Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.
AU  - Euden J
AU  - Albur M
AU  - Bestwick R
AU  - Bond S
AU  - Brookes-Howell L
AU  - Dark P
AU  - Gerver S
AU  - Grozeva D
AU  - Hamilton R
AU  - Heginbothom M
AU  - Hellyer T
AU  - Henley J
AU  - Hope R
AU  - Hopkins S
AU  - Howard P
AU  - Howdon D
AU  - King N
AU  - Knox-Macaulay C
AU  - Llewelyn M
AU  - Maboshe W
AU  - McCullagh I
AU  - Ogden M
AU  - Pallmann P
AU  - Parsons H
AU  - Partridge D
AU  - Powell N
AU  - Prestwich G
AU  - Richman C
AU  - Shaw D
AU  - Shinkins B
AU  - Szakmany T
AU  - Thomas-Jones E
AU  - Todd S
AU  - Webb E
AU  - West R
AU  - Carrol E
AU  - Sandoe J
AU  - PEACH Study Group
PY  - 2025
JO  - Health technology assessment (Winchester, England)
DO  - 10.3310/ggff9393
UR  - https://doi.org/10.3310/ggff9393
ER  - 

APA

J, E., M, A., R, B., S, B., L, B., P, D., S, G., D, G., R, H., M, H., T, H., J, H., R, H., S, H., P, H., D, H., N, K., C, K., M, L., W, M., I, M., M, O., P, P., H, P., D, P., N, P., G, P., C, R., D, S., B, S., T, S., E, T., S, T., E, W., R, W., E, C., J, S., & Group, P. S. (2025). Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.. Health technology assessment (Winchester, England). https://doi.org/10.3310/ggff9393

Source records